Genome sequences indicate the wide variety of characteristics which include species & sub-species type, genotype, diseases, growth indicators, yield quality, etc. To analyze and study these characteristics of the genome sequences across different species, various deep learning models have been proposed by researchers such as Convolutional Neural Networks (CNNs), Deep Belief Networks (DBNs), Multilayer Perceptron’s (MLPs), etc. which vary in terms of evaluation performance, area of application and species that are processed. Due to a wide differentiation between the algorithmic implementations, it becomes difficult for research programmer to select the best possible genome processing model for their application. In order to facilitate this selection, the paper reviews a wide variety of such models and compares their performance in terms of accuracy, area of application, computational complexity, processing delay, precision and recall. Thus, in the present review, various deep learning and machine learning models have different accuracies for different applications. For multiple genomic data, Repeated Incremental Pruning to Produce Error Reduction with Support Vector Machine (Ripper SVM) outputs 99.7% of accuracy and for cancer genomic data it gives 99.27% of accuracy using CNN Bayesian method. Whereas for Covid genome analysis Bidirectional Long Short-Term Memory with CNN (BiLSTM CNN) is having highest accuracy of 99.95%. The similar analysis of precision and recall of different models have been reviewed. Finally, this paper review concludes with some interesting observations about the genomic processing models and recommends applications for their efficient use.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.